Physician profile
Divya Goldstein
NPI 1891892907
$1,900.17
in general payments reported to CMS, 2019-2025
16 companies · $1,257 in 2025
The $1,257 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.90 · 2020: $60.73 · 2021: $125 · 2022: $109 · 2023: $158 · 2024: $92.66 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,033 · Travel and Lodging: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.79 |
| Travel and Lodging | $474.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,041.89 | 2023-2025 | Ffrct |
| Medtronic, INC. | $152.05 | 2025 | Aurora Ev-Icd Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $142.64 | 2020-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $124.60 | 2019-2022 | |
| Edwards Lifesciences Corporation | $114.31 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lantheus Medical Imaging, INC. | $49.28 | 2023-2024 | Definity |
| Amgen INC. | $45.30 | 2021-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $45.09 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $39.19 | 2021 | |
| Cardinal Health 200 LLC | $33.84 | 2020 | |
| Atricure, INC. | $26.68 | 2019 | |
| Abbott Laboratories | $24.55 | 2025 | Aveir |
| Glaxosmithkline, LLC. | $17.39 | 2025 | Arexvy, Shingrix |
| Pfizer INC. | $16.74 | 2023 | |
| Kiniksa Pharmaceuticals, Ltd. | $13.62 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.